| # | Title | Journal | Year | Citations |
|---|
| 1 | Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants | Leukemia | 2017 | 232 |
| 2 | An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome | Leukemia | 2014 | 175 |
| 3 | Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphoma | Leukemia | 2007 | 170 |
| 4 | Genetic Basis of Congenital Erythrocytosis: Mutation Update and Online Databases | Human Mutation | 2014 | 101 |
| 5 | Report on two novel nucleotide exchanges in the JAK2 pseudokinase domain: D620E and E627E | Leukemia | 2006 | 73 |
| 6 | Detection of JAK2 exon 12 mutations in 15 patients with JAK2V617F negative polycythemia vera | Haematologica | 2009 | 60 |
| 7 | Response to azacitidine is independent of p53 expression in higher-risk myelodysplastic syndromes and secondary acute myeloid leukemia | Haematologica | 2014 | 59 |
| 8 | Scalable Prediction of Acute Myeloid Leukemia Using High-Dimensional Machine Learning and Blood Transcriptomics | IScience | 2020 | 55 |
| 9 | KITD816V and JAK2V617F mutations are seen recurrently in hypereosinophilia of unknown significance | American Journal of Hematology | 2015 | 50 |
| 10 | High-risk additional chromosomal abnormalities at low blast counts herald death by CML | Leukemia | 2020 | 50 |
| 11 | Dynamics of Cytogenetic Aberrations in Philadelphia Chromosome Positive and Negative Hematopoiesis during Dasatinib Therapy of Chronic Myeloid Leukemia Patients after Imatinib Failure. | Blood | 2006 | 42 |
| 12 | Prognostic significance of combined MN1, ERG, BAALC, and EVI1 (MEBE) expression in patients with myelodysplastic syndromes | Annals of Hematology | 2012 | 37 |
| 13 | Comprehensive genetic diagnosis of acute myeloid leukemia by next-generation sequencing | Haematologica | 2019 | 33 |
| 14 | Biological and clinical characterization of recurrent 14q deletions in CLL and other mature B‐cell neoplasms | British Journal of Haematology | 2010 | 29 |
| 15 | The molecular pathogenesis of the NUP98-HOXA9 fusion protein in acute myeloid leukemia | Leukemia | 2017 | 28 |
| 16 | CDKN1B, encoding the cyclin-dependent kinase inhibitor 1B (p27), is located in the minimally deleted region of 12p abnormalities in myeloid malignancies and its low expression is a favorable prognostic marker in acute myeloid leukemia | Haematologica | 2011 | 26 |
| 17 | Multidimensional scaling analysis identifies pathological and prognostically relevant profiles of circulating T‐cells in chronic lymphocytic leukemia | International Journal of Cancer | 2014 | 23 |
| 18 | Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV | Haematologica | 2019 | 18 |
| 19 | Chromosome Banding Analysis Allows a More Precise Classification of CLL Than Interphase FISH: A Study on 446 Cases. | Blood | 2006 | 14 |
| 20 | High Frequency of AML1/RUNX1 Mutations in Specific Cytogenetic Subgroups in De Novo Acute Myeloid Leukemia. | Blood | 2007 | 14 |
| 21 | Chromosome Banding Analysis Defines Subclasses of CLL with 13q14 Deletion and Identifies a New Mechanism of Submicroscopic 13q14 Deletions Occurring in the Breakpoint Region of Reciprocal Translocations. | Blood | 2006 | 12 |
| 22 | Gain of the Short Arm of Chromosome 2 Is a New Recurring Chromosome Aberration in CLL Which Is Significantly Associated with an Unmutated IgGVH Status and a Complex Aberrant Karyotype and Leads to a Higher Expression of Genes Located on 2P. | Blood | 2007 | 12 |
| 23 | Molecular landscape of immune pressure and escape in aplastic anemia | Leukemia | 2023 | 11 |
| 24 | Molecular Response to First Line Imatinib Therapy Is Predictive for Long Term Event Free Survival in Patients with Chronic Phase Chronic Myelogenous Leukemia – An Interim Analysis of the Randomized German CML Study IV | Blood | 2008 | 10 |
| 25 | Characterization of a new myeloid leukemia cell line with normal cytogenetics (CG-SH) | Leukemia Research | 2009 | 9 |
| 26 | Randomized Comparison of Imatinib 400 Mg Vs. Imatinib + IFN Vs. Imatinib + AraC Vs. Imatinib after IFN Vs. Imatinib 800 Mg: Optimized Treatment and Survival. Designed First Interim Analysis of the German CML Study IV | Blood | 2008 | 8 |
| 27 | 5q Deletions Can Be Identified Based on the Expression Level of 5q Genes: A Study on 49 Cases with MDS or AML Analysed in Parallel by Gene Expression Profiling and Genomic Arrays. | Blood | 2006 | 8 |
| 28 | One-Mutation Model Can Explain Age Incidence in AML Carrying Nucleophosmin (NPM1) Mutations. | Blood | 2007 | 7 |
| 29 | Molecular and Cytogenetic Response After 3 Months of Imatinib Treatment Is Predictive for the Risk of Disease Progression and Death in Newly Diagnosed Chronic Myeloid Leukemia Patients – a Follow-up Analysis of the German CML Study IV | Blood | 2011 | 6 |
| 30 | Loss or Mutation of TP53 Is Highly Associated with Complex Aberrant Karyotype and Chromosomal Translocations in Chronic Lymphocytic Leukemia. | Blood | 2006 | 6 |
| 31 | Screening for TP53 Mutations Identifies Chronic Lymphocytic Leukemia Patients with Rapid Disease Progression. | Blood | 2007 | 5 |
| 32 | Single-Nucleotide Variants and Epimutations Induce Proteasome Inhibitor Resistance in Multiple Myeloma | Clinical Cancer Research | 2023 | 5 |
| 33 | Toxicomanie d’un parent et appréciation des capacités parentales par les tribunaux québécois | Drogues, Santé Et Société | 2002 | 4 |
| 34 | A case of chronic myeloproliferative syndrome followed by precursor T-cell acute lymphoblastic leukemia | Cancer Genetics and Cytogenetics | 2007 | 4 |
| 35 | Real-Time Quantitative PCR (RQ-PCR) Detection of Minimal Residual Disease (MRD) by Optimized WT1 Assay To Enhance Risk Stratification in Acute Myeloid Leukemia (AML): A European LeukemiaNet Study. | Blood | 2007 | 4 |
| 36 | Imatinib failure and response to dasatinib in a patient with chronic myeloid leukemia in blast crisis and a novel, nine-nucleotide BCR-ABL insertion mutation | Blood Cancer Journal | 2013 | 3 |
| 37 | The Cytogenetic Profile In Lymphoid and Myeloid CML Blast Crisis | Blood | 2013 | 3 |
| 38 | Impact of emerging ACA on survival in chronic myeloid leukemia (CML) | Leukemia | 2022 | 3 |
| 39 | Transfusion Independency and Histological Remission in a Patient with Advanced Primary Myelofibrosis Receiving Iron-Chelation Therapy with Deferasirox | Oncology Research and Treatment | 2016 | 2 |
| 40 | Nucleophosmin Gene Mutations Are Predictors of Favourable Prognosis in Acute Myeloid Leukemia with a Normal Kayotype and Can Be Used as a New Marker for Quantitative PCR To Detect Minimal Residual Disease. | Blood | 2005 | 2 |
| 41 | Correlation of Flow Cytometrically Determined Expression of ZAP-70 Using Two Different Antibodies with IgVH Mutation Status and Cytogenetics in 539 Patients with Chronic Lymphocytic Leukemia. | Blood | 2006 | 2 |
| 42 | Trisomy 13 Defines a Subgroup of Myeloid Malignancies with an Extremely High Frequency of AML1 Gene Mutations and Newly Defined VEGFR-1 Mutations. | Blood | 2006 | 2 |
| 43 | The Number of Cooperating Mutations in AML Is Still Growing: A Study on 3789 Patients. | Blood | 2006 | 2 |
| 44 | Individual Gene Expression Profiling of Bone Marrow CD34 Cells in Acquired Severe Aplastic Anemia (aSAA) in Children. | Blood | 2006 | 2 |
| 45 | Aberrations identified by genomic arrays in normal karyotype CMML can be detected in 40% of patients, but do not add prognostic information to molecular mutations | Leukemia | 2016 | 1 |
| 46 | JAK2V617F as a Cooperative Mutation in AML with Trisomy 8 and t(8;21): A Comparative Study on 271 AML and 1103 CMPD Cases. | Blood | 2006 | 1 |
| 47 | In CML, Marrow Fibrosis Relapses or Emerges in 5 - 6 % of Patients Per Year Independently Indicating Imatinib Failure and Shortened Survival Time of Patients. | Blood | 2006 | 1 |
| 48 | 3′ Position of the FLT3-LM and Loss of Heterozygosity Are Highly Correlated to Unfavourable Outcome in AML. | Blood | 2006 | 1 |
| 49 | Flow Cytometric Determination of ZAP-70 Expression by SBZAP Antibody: Impact of Type of Data Analysis on Correlation with IgVH Mutation Status, Cytogenetics, and Level of ZAP-70 mRNA Expression in 351 Patients with Chronic Lymphocytic Leukemia (CLL). | Blood | 2007 | 1 |
| 50 | PHF6 - Somatic Mutations and Their Role in Pathophysiology of MDS and AML | Blood | 2015 | 1 |
